About the Authors
- Gitanjali M. Singh
-
Contributed equally to this work with: Gitanjali M. Singh, Renata Micha
Affiliation Friedman School of Nutrition Science and Health Policy, Tufts University, Boston, MA, United States of America
- Renata Micha
-
Contributed equally to this work with: Gitanjali M. Singh, Renata Micha
Affiliations Friedman School of Nutrition Science and Health Policy, Tufts University, Boston, MA, United States of America, Department of Food Science and Human Nutrition, Agricultural University of Athens, Athens, Greece
- Shahab Khatibzadeh
-
Affiliation Department of Epidemiology, Harvard School of Public Health, Boston, MA, United States of America
- Peilin Shi
-
Affiliation Friedman School of Nutrition Science and Health Policy, Tufts University, Boston, MA, United States of America
- Stephen Lim
-
Affiliation Institute of Health Metrics and Evaluation, Seattle, WA, United States of America
- Kathryn G. Andrews
-
Affiliation Institute of Health Metrics and Evaluation, Seattle, WA, United States of America
- Rebecca E. Engell
-
Affiliation Institute of Health Metrics and Evaluation, Seattle, WA, United States of America
- Majid Ezzati
-
Affiliation Department of Global Environmental Health, School of Public Health, Imperial College London, London, United Kingdom
- Dariush Mozaffarian
-
* E-mail: Dariush.Mozaffarian@tufts.edu
Affiliation Friedman School of Nutrition Science and Health Policy, Tufts University, Boston, MA, United States of America
- Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE)
-
¶Membership of the NutriCoDE author group is provided in the Acknowledgments.
Competing Interests
The authors would like to provide the following disclosures: Dr. Mozaffarian reports research grants from GlaxoSmithKline, Sigma Tau, Pronova, and the National Institutes of Health for a completed investigator-initiated, not-for-profit, randomized clinical trial of fish oil supplements for the prevention of post-surgical complications; ad hoc travel reimbursement and/or honoraria for one-time scientific presentations or reviews on diet and cardiometabolic diseases from Bunge, Pollock Institute, Quaker Oats, and Life Sciences Research Organization (each modest); ad hoc consulting fees from McKinsey Health Systems Institute, Foodminds, and Nutrition Impact (each modest); Unilever North America Scientific Advisory Board membership (modest); and royalties from UpToDate, for an online chapter on fish oil (modest). Harvard University has filed a provisional patent application, that has been assigned to Harvard University, listing Dr. Mozaffarian as a co-inventor to the US Patent and Trademark Office for use of trans-palmitoleic acid to prevent and treat insulin resistance, type 2 diabetes, and related conditions (Patent name: “Use of trans-palmitoleate in identifying and treating metabolic disease”; Patent number: 8,889,739). All other authors declare that they have no conflicts of interest. This information does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: GMS RM SK PS SL KGA REE ME DM. Analyzed the data: GMS RM SK PS KGA REE. Contributed reagents/materials/analysis tools: GMS RM SK PS KGA REE SL ME DM. Wrote the paper: GMS RM DM.